Rishabh instruments Limited has announced the availability of its Q3 FY 2025-26 earnings conference call audio recording on its official website. The company made this disclosure to the National Stock Exchange of India Limited and BSE Limited on February 6, 2026, in compliance with regulatory requirements.

Conference Call Details

The earnings conference call for Q3 FY 2025-26 was conducted on February 6, 2026. Following the call, the company has uploaded the complete audio recording to ensure transparency and accessibility for stakeholders.

Regulatory Compliance

The disclosure was made pursuant to the applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This regulatory framework mandates listed companies to maintain transparency in their financial communications and ensure stakeholder access to material information.

Accessibility and Documentation

The audio recording has been made available on the company's website at https://rishabh.co.in/quarterly-filings under the Stock Exchange Information section. This ensures that investors, analysts, and other stakeholders can access the complete discussion from the earnings call.

The company has indicated that the transcript of the earnings conference call will be uploaded to the website and submitted to the stock exchanges in due course, providing additional documentation for stakeholder reference.

Corporate Communication

The announcement was signed by Ajinkya Joglekar, Company Secretary and Compliance Officer, who holds ICSI Membership No. A57272. The digital signature was applied on February 6, 2026, at 16:43:21 +05'30', ensuring the authenticity and timeliness of the regulatory filing.

Rishabh Instruments Limited has submitted its quarterly statement on fund utilization deviation to the stock exchanges for the quarter ended December 31, 2025, in compliance with SEBI regulations. The filing reveals modifications to the company's original fund utilization plan following shareholder approval.

Fund Raising Details

The company's fund raising particulars demonstrate a structured approach to capital deployment:

Modified Fund Utilization Plan

The company has restructured its original manufacturing expansion strategy with shareholder consent. The modification involved splitting the original Nashik Manufacturing Facility I expansion into two separate facilities with revised fund allocations.

Utilization Progress

The fund utilization shows significant progress across the modified objectives. The original Nashik Manufacturing Facility I expansion, now allocated Rs. 321.80 million, has utilized Rs. 224.31 million. The newly created Nashik Manufacturing Facility II, with an allocation of Rs. 300.00 million, has deployed Rs. 204.19 million and reported a quarterly deviation of Rs. 34.45 million.

Regulatory Compliance

The statement confirms that the deviation in fund utilization was implemented pursuant to changes in contract terms and objects, which received proper shareholder approval on September 13, 2024. Both the Audit Committee and auditors have provided nil comments on the fund utilization pattern, indicating compliance with regulatory requirements.

Corporate Governance

The filing was signed by Ajinkya Joglekar, Company Secretary and Compliance Officer, and submitted to both NSE (Symbol: RISHABH) and BSE (Scrip Code: 543977) on February 5, 2026. The company maintains its commitment to transparent reporting under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.